Financhill
Buy
53

CROX Quote, Financials, Valuation and Earnings

Last price:
$90.61
Seasonality move :
2.76%
Day range:
$89.19 - $91.14
52-week range:
$73.21 - $122.84
Dividend yield:
0%
P/E ratio:
29.54x
P/S ratio:
1.25x
P/B ratio:
3.45x
Volume:
533.6K
Avg. volume:
1.4M
1-year change:
-19.3%
Market cap:
$4.7B
Revenue:
$4.1B
EPS (TTM):
$3.07

Earnings Data

Next earnings date for CROX
Feb 12
2026
Most recent earnings per share
$2.70
Beat by $0.34
(Oct 30/2025)
Consensus Estimate
$2.36
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CROX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2026 Q4 $916.2M -- -- $1.91 --
10/30/2025 Q3 $961.5M $996.3M $2.70 $2.36 $0.34
08/07/2025 Q2 $1.1B $1.1B -$8.83 $4.02 -$12.84
05/08/2025 Q1 $907.9M $937.3M $2.83 $2.49 $0.35
02/13/2025 Q4 $961.1M $989.8M $6.36 $2.26 $4.09
10/29/2024 Q3 $1.1B $1.1B $3.36 $3.11 $0.25
08/01/2024 Q2 $1.1B $1.1B $3.77 $3.57 $0.20
05/07/2024 Q1 $884.7M $938.6M $2.50 $2.25 $0.25
02/15/2024 Q4 $958.5M $960.1M $4.16 $2.37 $1.79
11/02/2023 Q3 -- -- $2.87 $3.13 -$0.26
07/27/2023 Q2 -- -- $3.39 $2.98 $0.41
04/27/2023 Q1 -- -- $2.39 $2.16 $0.23
02/16/2023 Q4 -- -- $2.20 $2.26 -$0.06
11/03/2022 Q3 -- -- $2.72 $2.61 $0.11
08/04/2022 Q2 -- -- $2.58 $2.67 -$0.09
05/05/2022 Q1 -- -- $1.19 $1.55 -$0.36
02/16/2022 Q4 -- -- $2.57 $1.90 $0.67
10/21/2021 Q3 -- -- $2.42 $1.86 $0.56
07/22/2021 Q2 -- -- $4.93 $1.59 $3.34
04/27/2021 Q1 -- -- $1.47 $0.89 $0.58
02/23/2021 Q4 -- -- $2.69 $0.79 $1.90
10/27/2020 Q3 -- -- $0.91 $0.70 $0.21
07/30/2020 Q2 -- -- $0.83 $0.08 $0.75
04/23/2020 Q1 -- -- $0.16 $0.35 -$0.19
02/27/2020 Q4 -- -- $0.29 $0.08 $0.22
10/30/2019 Q3 -- -- $0.51 $0.39 $0.12
08/01/2019 Q2 -- -- $0.55 $0.45 $0.10
05/07/2019 Q1 -- -- $0.33 $0.24 $0.09
02/28/2019 Q4 -- -- -$1.72 -- --
11/08/2018 Q3 -- -- $0.07 -- --
08/07/2018 Q2 -- -- $0.35 -- --
05/08/2018 Q1 -- -- $0.15 -- --
02/28/2018 Q4 -- -- -$0.41 -- --
11/07/2017 Q3 -- -- -$0.03 -- --
08/09/2017 Q2 -- -- $0.20 -- --
05/10/2017 Q1 -- -- $0.08 -- --
03/01/2017 Q4 -- -- -$0.60 -- --
11/09/2016 Q3 -- -- -$0.07 -- --
08/03/2016 Q2 -- -- $0.13 -- --
05/10/2016 Q1 -- -- $0.07 -- --
02/29/2016 Q4 -- -- -$1.01 -- --

Crocs, Inc. Earnings Questions

  • How Much did Crocs, Inc. Generate in Revenue Last Quarter?

    Crocs, Inc. reported $996.3M worth of top line sales in its most recent quarter.

  • Did Crocs, Inc. Beat Earnings Last Quarter?

    Crocs, Inc. announced earnings per share of $2.70 which represents a beat of analyst forecast a $2.36 per share.

  • Is Crocs, Inc. Profitable?

    Crocs, Inc. reported $583M that represents $10.80 per share over the last quarter.

  • What is the Analyst Consensus for Crocs, Inc. EPS Next Year?

    Crocs, Inc.'s earnings are forecast to decrease from $15.88 per share to $12.90 per share next year representing a decrease of -23.58%.

  • When is Crocs, Inc.'s Earnings Date?

    Crocs, Inc.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock